About Michael Carusi
Form D filings for MediSix Therapeutics from 2019 to 2023 list Michael Carusi as director.
Michael Carusi first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Carusi in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Carusi works with at each company, as listed on that company's latest Form D.
MediSix Therapeutics, Inc. · Form D/A, Aug 4, 2023